These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1134893)

  • 1. Letter: Methylphenidate reaction.
    Sleator EK
    Pediatrics; 1975 Jun; 55(6):895-6. PubMed ID: 1134893
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of methylphenidate for attention deficit hyperactivity disorder. Mental Health Committee, Canadian Paediatric Society.
    CMAJ; 1990 Apr; 142(8):817-8. PubMed ID: 2322913
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'.
    Olders H
    J Pediatr Psychol; 2009; 34(1):108-9; author reply 110-2. PubMed ID: 19136567
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylphenidate revisited.
    Med Lett Drugs Ther; 1988 May; 30(765):51-2. PubMed ID: 3362094
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of methylphenidate for attention deficit hyperactivity disorder.
    Kline CL
    CMAJ; 1990 Aug; 143(3):170-2. PubMed ID: 2073248
    [No Abstract]   [Full Text] [Related]  

  • 6. Methylphenidate in children with minimal brain dysfunction: effects on attention span, visual-motor skills, and behavior.
    Seger EY; Hallum G
    Curr Ther Res Clin Exp; 1974 Jun; 16(6):635-41. PubMed ID: 4211145
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained-release methylphenidate.
    Med Lett Drugs Ther; 1984 Oct; 26(673):97-8. PubMed ID: 6384753
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of stimulant medications in children.
    Morgan AM
    Am Fam Physician; 1988 Oct; 38(4):197-202. PubMed ID: 3051976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 10. A drug to ease attention deficit-hyperactivity disorder.
    Smitherman CH
    MCN Am J Matern Child Nurs; 1990; 15(6):362-5. PubMed ID: 2124318
    [No Abstract]   [Full Text] [Related]  

  • 11. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR
    J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
    [No Abstract]   [Full Text] [Related]  

  • 12. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
    Taéron C
    Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.
    Handen BL; Breaux AM; Gosling A; Ploof DL; Feldman H
    Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
    Ghanizadeh A
    J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract]   [Full Text] [Related]  

  • 18. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate-induced delusional disorder in a child with attention deficit disorder with hyperactivity.
    Bloom AS; Russell LJ; Weisskopf B; Blackerby JL
    J Am Acad Child Adolesc Psychiatry; 1988 Jan; 27(1):88-9. PubMed ID: 3343212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.